Patent details

Basic Information

Publication number:

EP3749286

PCT Application Number:

EP2019052557

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP197026164

PCT Publication Number:

WO2019149917

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

A PHARMACEUTICAL COMPOSITION COMPRISING METAMIZOLE, DROTAVERINE, AND CAFFEINE

French Title of Invention:

COMPOSITION PHARMACEUTIQUE COMPRENANT DU METAMIZOLE, DE LA DROTAVÉRINE ET DE LA CAFÉINE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNG, UMFASSEND METAMIZOL, DROTAVERIN UND KOFFEIN

SPC Number:

Dates

Filing date:

02/02/2019

Grant date:

23/10/2024

EP Publication Date:

16/12/2020

PCT Publication Date:

08/08/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/10/2024

EP B1 Publication Date:

23/10/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/02/2025

Expiration date:

02/02/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/10/2024

 

 

Name:

Adamed Pharma S.A.

Address:

Pienkow ul. Mariana Adamkiewicza 6A, 05-152 Czosnow, Poland (PL)

Inventor

1

Name:

CIEPLUCHA, Agnieszka

Address:

Poland (PL)

2

Name:

NIEMCZYK, Katarzyna

Address:

Poland (PL)

Priority

Priority Number:

18461514

Priority Date:

05/02/2018

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 9/16; A61K 31/4152; A61K 31/472; A61K 31/522; A61K 9/24;

Publication

European Patent Bulletin

Issue number:

202443

Publication date:

23/10/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages